NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives. (Q37942795)
Jump to navigation
Jump to search
scientific article published on September 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives. |
scientific article published on September 2011 |
Statements
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives (English)
Ursula A Matulonis
Islah Ahmed
Edward Louis Braud
James D Cross
Nancy Davenport-Ennis
Barry D Dickinson
Steven E Goldberg
Scott Gottlieb
Philip E Johnson
Gary H Lyman
Richard Markus
Denise Reinke
Edward C Li
Jessica DeMartino
Jonathan K Larsen
James M Hoffman
1 September 2011